Budesonide And Formoterol Fumarate Dihydrate Aerosol
Pricing Report NDC 0310-7370-20

Current NADAC: $17.46899 per GM · Effective Aug 19, 2026
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Budesonide And Formoterol Fumarate Dihydrate (NDC 0310-7370-20) is $17.46899 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 1 POUCH in 1 CARTON / 1 CANISTER in 1 POUCH / 120 AEROSOL in 1 CANISTER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$17.46899
Per GM

Pricing Unit
Per GM Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
0310-7370-20
Description
1 POUCH in 1 CARTON / 1 CANISTER in 1 POUCH / 120 AEROSOL in 1 CANISTER
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2020, the NADAC wholesale price for (NDC ) has moved within a range of $16.28231 to $23.72900 per GM. Over this 6 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$16.2823 - $23.7290
Market Volatility
45.73% Variance
Latest Trend
1.09%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $17.46899 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 22, 2026 $17.66073 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 17, 2026 $18.17243 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 20, 2026 $18.86704 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 22, 2026 $19.41248 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 18, 2026 $20.06802 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 18, 2026 $19.82575 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 21, 2026 $20.22749 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 17, 2025 $19.78806 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 19, 2025 $19.43961 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 22, 2025 $18.81229 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 17, 2025 $18.71151 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026